We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Analytical Tools Reveal Molecular Mechanism of Gene-Editing Tool

By LabMedica International staff writers
Posted on 10 Dec 2018
Print article
Image: Illustration showing the protein Cas12a (Cpf1) bound to a DNA helix (red and white) (Photo courtesy of T. Yamano and H. Nishimasu, who discovered and published the coordinates of each atom in the protein-DNA complex. James Rybarski used those coordinates and software called PyMol to generate the illustration).
Image: Illustration showing the protein Cas12a (Cpf1) bound to a DNA helix (red and white) (Photo courtesy of T. Yamano and H. Nishimasu, who discovered and published the coordinates of each atom in the protein-DNA complex. James Rybarski used those coordinates and software called PyMol to generate the illustration).
A recent paper described the use of advanced analytical techniques to define the mode of action of the gene-editing tool CRISPR/cas12.

Despite the widespread usage of CRISPR/Cas9, DNA cleavage at off-target sites that resemble the target sequence continues to be a pervasive problem that remains poorly understood mechanistically. To solve the problem of off-target DNA cleavage, investigators at the University of Copenhagen (Denmark) utilized cryo-electron microscopy (cryo-EM) and single-molecule FRET (fluorescence resonance energy transfer) to dissect the reaction steps of DNA targeting by Cas12a (also known as Cpf1 or centromere and promoter factor 1).

Cryo-EM is an analytical technique that provides near-atomic structural resolution without requirements for crystallization or limits on molecular size and complexity imposed by the other techniques. Cryo-EM allows the observation of specimens that have not been stained or fixed in any way, showing them in their native environment while integrating multiple images to form a three-dimensional model of the sample.

Fluorescence resonance energy transfer (FRET) is a mechanism describing energy transfer between two light-sensitive molecules (chromophores). A donor chromophore, initially in its electronic excited state, may transfer energy to an acceptor chromophore through non-radiative dipole–dipole coupling. The efficiency of this energy transfer is inversely proportional to the sixth power of the distance between donor and acceptor, making FRET extremely sensitive to small changes in distance. FRET can be used to measure distances between domains in a single protein and therefore to provide information about protein conformation.

CRISPR/Cas9 is regarded as the cutting edge of molecular biology technology. CRISPRs (clustered regularly interspaced short palindromic repeats) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacterial virus or plasmid. Since 2013, the CRISPR/Cas9 system has been used in research for gene editing (adding, disrupting, or changing the sequence of specific genes) and gene regulation. By delivering the cas9 enzyme and appropriate guide RNAs (sgRNAs) into a cell, the organism's genome can be cut at any desired location. The conventional CRISPR/Cas9 system is composed of two parts: the Cas9 enzyme, which cleaves the DNA molecule and specific RNA guides that shepherd the Cas9 protein to the target gene on a DNA strand.

CRISPR/Cpf1 differs from CRISPR/Cas9 in a number of key ways. Cpf1 is much smaller than the Cas9 enzyme, which makes it easier to package inside a virus and therefore easier to deliver to cells. It also recognizes a different sequence of DNA than Cas9 does, which provides greater flexibility in terms of use.

In a paper published in the November 29, 2018, online edition of the journal Cell the investigators revealed cryo-EM structures of intermediates of the cleavage reaction, thus visualizing three protein regions that sensed the crRNA-DNA hybrid assembly triggering the catalytic activation of Cas12a. Single-molecule FRET provided the thermodynamics and kinetics of the conformational activation leading to phosphodiester bond hydrolysis. These findings illustrated why Cas12a cut its target DNA and unleashed unspecific cleavage activity, degrading ssDNA (single strand DNA) molecules after activation.

"If we compare CRISPR to a car engine, what we have done is to make a complete three-dimensional map of the engine and thus gain an understanding of how it works. This knowledge will enable us to fine-tune the CRISPR engine and make it work in various ways – as a Formula One racer as well as an off-road truck", said senior author Dr. Guillermo Montoya, research director and group leader at the protein structure and function program at the University of Copenhagen.

Related Links:
University of Copenhagen

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.